Bosentan & Product dose omission issue

17.4%

of users reported Product dose omission issue

47.1%

also reported Hospitalization

78.9%

are women

Hospitalization

47.1%

Severe reaction

47.1%

Life-threatening condition

5.9%

Bosentan: general information

0 - 9 years

17.9%

10 - 19 years

<0.1%

20 - 29 years

<0.1%

30 - 39 years

<0.1%

40 - 49 years

<0.1%

50 - 59 years

26.5%

60 - 69 years

14.5%

70 - 79 years

41.0%